Elevation Oncology Reports Financial Obligation Event
| Field | Detail |
|---|---|
| Company | Elevation Oncology, Inc. |
| Form Type | 8-K |
| Filed Date | Apr 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: debt, financial-obligation
TL;DR
Elevation Oncology's 8-K: Financial obligation accelerated or increased. Watch for details.
AI Summary
On April 3, 2025, Elevation Oncology, Inc. filed an 8-K report to disclose a triggering event that accelerates or increases a direct financial obligation. The filing indicates a change in the company's financial obligations, though specific details of the obligation and the acceleration or increase are not provided in this excerpt.
Why It Matters
This filing signals a potential change in Elevation Oncology's financial commitments, which could impact its liquidity and future financial strategy.
Risk Assessment
Risk Level: medium — The filing indicates a change in financial obligations, which could have material implications for the company's financial health.
Key Players & Entities
- Elevation Oncology, Inc. (company) — Registrant
- 0001783032 (company) — Central Index Key
- 001-40523 (company) — SEC File Number
- 84-1771427 (company) — IRS Employer Identification No.
- 101 Federal Street, Suite 1900 Boston, Massachusetts 02110 (company) — Business Address
- April 3, 2025 (date) — Date of earliest event reported
FAQ
What specific financial obligation is being accelerated or increased?
The provided excerpt does not specify the exact financial obligation, only that a triggering event has occurred.
What is the amount of the acceleration or increase in the financial obligation?
The filing excerpt does not contain information regarding the monetary amount of the accelerated or increased obligation.
What is the nature of the 'triggering event' mentioned in the filing?
The filing indicates a triggering event occurred, but the specific nature of this event is not detailed in the provided text.
When did the triggering event occur?
The triggering event occurred on or before April 3, 2025, as this is the date of the earliest event reported.
What is the former name of Elevation Oncology, Inc. and when did the name change occur?
The former name was 14ner Oncology, Inc., and the name change occurred on July 19, 2019.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 4, 2025 regarding Elevation Oncology, Inc..